Anti-infection Antibody-Drug Conjugate/ADC Related Apoptosis Autophagy Cell Cycle/DNA Damage Cytoskeleton Epigenetics GPCR/G Protein Immunology/Inflammation JAK/STAT Signaling MAPK/ERK Pathway Membrane Transporter/Ion Channel Metabolic Enzyme/Protease Neuronal Signaling NF-B PI3K/Akt/mTOR PROTAC Protein Tyrosine Kinase/RTK Stem Cell/Wnt TGF-beta/Smad Vitamin D Related/Nuclear Receptor Others Hot Products Compound Screening Libraries Recombinant Proteins Life Science Kits Oligonucleotides Isotope-Labeled Compounds Natural Products Fluorescent Dyes Peptides Inhibitory Antibodies Biochemical Assay Reagents Antibodies Enzymes Reference Standards Induced Disease Models Products GMP Small Molecules Click Chemistry Adjuvants Lipids Saccharides Hot Topics More Restoring Immune Tolerance: New Insights into Autoimmune Disease Research 2026-07-22 Beyond GLP-1: Reprogramming Metabolism Through Next-Generation Therapeutics 2026-07-16 Beyond Traditional Virtual Screening: New Perspectives on AI-Driven Drug Discovery 2026-07-09 Beyond G12C: Emerging Frontiers in KRAS-Targeted Cancer Research 2026-07-02 Nature
Biosynthesis and Biotechnological Synthesis of Hydroxytyrosol
It received FDA approval in December 2013 to treat Peyronies disease
Glutamine metabolism and drug resistance Glutamine plays a pivotal role in the progression of tumors, and the strategic limitation of its availability is emerging as a potential therapeutic approach
Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA
The debate illustrates the broader challenges of upholding justice in planning when multiple and sometimes conflicting valuespublic preference, expert knowledge, cultural heritage, and sustainabilitymust be reconciled
